Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: A role for the NPR-C receptor

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 5 55-5, 2004, Pages

  Rose, Robert A ^a   Lomax, Alan E ^a   Kondo, Colleen S ^a   Anand Srivastava, Madhu B ^b   Giles, Wayne R ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

C receptor; Calcium current; Hyperpolarization activated current

Indexed keywords

ISOPRENALINE; NATRIURETIC PEPTIDE TYPE C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; GENE SEQUENCE; HEART PERFUSION; HYPERPOLARIZATION; ION CURRENT; MOUSE; MUSCLE CELL; NONHUMAN; PACEMAKER; PRIORITY JOURNAL; SINUS NODE; VOLTAGE CLAMP;

ANIMALS; CALCIUM CHANNELS, L-TYPE; ELECTRIC CONDUCTIVITY; ELECTROCARDIOGRAPHY; GUANYLATE CYCLASE; HEART RATE; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, C-TYPE; PEPTIDE FRAGMENTS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SINOATRIAL NODE;

EID: 1942533427     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00893.2003     Document Type: Article

References (52)

1. Accili E, Proenza C, Baruscotti M, and DiFrancesco D. From funny current to HCN channels: 20 years of excitation. News Physiol Sci 17: 32-37, 2002.
2. Anand-Srivastava MB, Sairam MR, and Cantin M. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. J Biol Chem 265: 8566-8572, 1990.
3. Anand-Srivastava MB, Sehl PD, and Lowe DG. Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. J Biol Chem 271: 19324-19329, 1996.
4. Anand-Srivastava MB and Trachte GJ. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 45: 455-497, 1993.
5. Anand-Srivastava M and Cantin M. Atrial natriuretic factor receptors are negatively coupled to adenylate cyclase in cultured atrial and ventricular cardiocytes. Biochem Biophys Res Commun 138: 427-436, 1986.
6. Barr CS, Rhodes P, and Struthers AD. C-type natriuretic peptide. Peptides 17: 1243-1251, 1996.
7. Bers DM and Ziolo MT. When is cAMP not cAMP? Effects of compartmentalization. Circ Res 89: 373-375, 2001.
8. Campbell D, Rasmusson R, and Strauss H. Ionic current mechanisms generating vertebrate primary cardiac pacemaker activity at the single cell level: an integrative view. Annu Rev Physiol 54: 279-302, 1992.
9. Chen HH and Burnett JJ. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 32: S22-S28, 1998.
10. 2+ channels. Biophys J 79: 2547-2556, 2000.
11. Cho HS, Takano M, and Noma A. The electrophysiological properties of spontaneously beating pacemaker cells isolated from mouse sinoatrial node. J Physiol 550: 169-180, 2003.
12. Darbar D, Davidson NC, Gillespie N, Choy AJ, Lang CC, Shyr Y, McNeill GP, Pringle TH, and Struthers AD. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 78: 284-287, 1996.
13. DiFrancesco D. Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol 55: 455-472, 1993.
14. DiFrancesco D and Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 351: 145-147, 1991.
15. Doyle DD, Upshaw-Earley J, Bell EL, and Palfrey HC. Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population. Am J Physiol Heart Circ Physiol 282: H2117-H2123, 2002.
16. Fischmeister R and Hartzell HC. Mechanism of action of acetylcholine on calcium current in single cells from frog ventricle. J Physiol 376: 183-202, 1986.
17. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85-100, 1981.
18. Ca-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95: 6510-6515, 1998.
19. Herring N, Zaman JAB, and Paterson DJ. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway. Am J Physiol Heart Circ Physiol 281: H2318-H2327, 2001.
20. Hove-Madsen L, Mery PF, Jurevicius J, Skeberdis A, and Fischmeister R. Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res Cardiol 91 Suppl 2: 1-8, 1996.
21. 2+ channels by β-adrenergic agonists. Proc Natl Acad Sci USA 93: 295-299, 1996.
22. Kamp TJ and Hell JW. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87: 1095-1102, 2000.
23. Kaupp U and Seifert R. Molecular diversity of pacemaker ion channels. Annu Rev Physiol 63: 235-257, 2001.
24. 2-adrenergic signaling. J Biol Chem 274: 22048-22052, 1999.
25. 2-Adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. Circulation 99: 2458-2465, 1999.
26. + channel, Kir3.1/Kir34. J Biol Chem 275: 35831-35839, 2000.
27. Levin ER, Gardner DG, and Samson WK. Natriuretic peptides. N Engl J Med 339: 321-328, 1998.
28. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, and Waldman SA. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52: 375-413, 2000.
29. Lueger A, Brodmann M, Scherr D, and Stark G. The influence of magnesium on the electrophysiological effects of erythromycin in the isolated guinea pig heart. Cardiovasc Drugs Ther 16: 327-333, 2002.
30. Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol 54: 11-27, 1992.
31. 2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci USA 100: 5543-5548, 2003.
32. f) in isolated mouse sino-atrial cells. Cardiovasc Res 52: 51-64, 2001.
33. Matsuda Y. Design and utilization of natriuretic peptide antagonists. In: Contemporary Endocrinology: Natriuretic Peptides in Health and Disease, edited by Samson WK and Levin ER. Totowa, NJ: Humana, 1997, p. 289-307.
34. Matsuda Y and Morishita Y. HS-142-1: a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. Cardiovasc Drug Rev 11: 45-59, 1993.
35. Milnor W. Electrical activity of the heart. In: Cardiovascular Physiology. Oxford, UK: Oxford University Press, 1990, p. 140-170.
36. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, and Nakao K. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88: 82-91, 1993.
37. i-2-dependent signaling by single-transmembrane natriuretic peptide clearance receptor. Am J Physiol Gastrointest Liver Physiol 278: G974-G980, 2000.
38. Murthy KS and Makhlouf GM. Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C). J Biol Chem 274: 17587-17592, 1999.
39. Nunez D, Dickson M, and Brown M. Natriuretic peptide receptor mRNAs in the rat and human heart. J Clin Invest 90: 1966-1971, 1992.
40. Ogawa Y, Nakao K, Nakagawa O, Komatsu Y, Hosoda K, Suga S, Arai H, Nagata K, Yoshida N, and Imura H. Human C-type natriuretic peptide: characterization of the gene and peptide. Hypertension 19: 809-813, 1992.
41. Okamoto T, Katada T, Murayama Y, Ui M, Ogata E, and Nishimoto I. A simple structure encodes G protein-activating function of the IGF-II/mannose 6-phosphate receptor. Cell 62: 709-717, 1990.
42. 2-adrenergic receptors based on characteristics in primary structure. J Biol Chem 267: 8342-8346, 1992.
43. Omland T, Aakvaag A, Bonarjee VVS, Caidahl K, Lie RT, Nilsen DWT, Sundsfjord JA, and Dickstein K. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation 93: 1963-1969, 1996.
44. i activator sequences that inhibit adenylyl cyclase activity. J Biol Chem 276: 22064-22070, 2001.
45. Rose RA, Lomax AE, and Giles WR. Inhibition of L-type calcium current by C-type natriuretic peptide in bullfrog atrial myocytes: an NPR-C-mediated effect. Am J Physiol Heart Circ Physiol 285: H2454-H2462, 2003.
46. Schwartz JH. The many dimensions of cAMP signaling. Proc Natl Acad Sci USA 98: 13482-13484, 2001.
47. Steinberg SF and Brunton LL. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu Rev Pharmacol Toxicol 41: 751-753, 2001.
48. 2+ current to electrical activity in sinoatrial nodal myocytes of rabbits. Am J Physiol Heart Circ Physiol 276: H1064-H1077, 1999.
49. Vollmar A, Gerbes A, Nemer M, and Schulz R. Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs. Endocrinology 132: 1872-1874, 1993.
50. Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CGA, Edwards WD, Schaff HV, and Burnett JJ. Natriuretic peptide system in human heart failure. Circulation 88: 1004-1009, 1993.
51. Yandle TG. Biochemistry of natriuretic peptides. J Intern Med 235: 561-576, 1994.
52. Zhou H and Murthy KS. Identification of the G protein-activating sequence of the single-transmembrane natriuretic peptide receptor C (NPR-C). Am J Physiol Cell Physiol 284: C1255-C1261, 2003.